Targeted overexpression of relaxin receptor 1 (RXFP1) with chronic administration of relaxin as a novel inotropic approach for heart failure treatment [PDF]
Nuttarak Sasipong
openalex +1 more source
Relaxin Concentrations in Endometrial, Placental, and Ovarian Tissues and in Sera from Ewes During Middle and Late Pregnancy1 [PDF]
Randall H. Renegar, Lynn H. Larkin
openalex +1 more source
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer [PDF]
Joanna Białek +4 more
openalex +1 more source
Insulin-like 3/Relaxin-Like Factor Gene Mutations Are Associated with Cryptorchidism1 [PDF]
Marlah Tomboc +5 more
openalex +1 more source
Characterization of relaxin binding in the uterus of the marmoset monkey [PDF]
A. Einspanier
openalex +1 more source
Localization of Relaxin in the Pregnant Rat. Bioassay of Tissue Extracts and Cell Fractionation Studies [PDF]
Mary L. Anderson, John A. Long
openalex +1 more source
Relaxin 2004: Fourth International Conference on Relaxin and Related Peptides, September 5–10, 2004, Grand Teton National Park, Jackson Hole, Wyoming [PDF]
openalex +1 more source
Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2/HO-1 Signalling Pathway in Gastric Cancer Cells. [PDF]
Liguo Wang, Yi Zhou, Hui Lin, Kezhu Hou
openalex +1 more source
On November 25, 2024, Eli Lilly and Company informed the public about the decision to terminate their phase-2 study, J3E-MC-EZDB with the relaxin-2 analogue, LY3540378, after data analysis of 40% of participants had indicated futility without immediate ...
Thomas Bernd Dschietzig, Guy Salama
doaj +1 more source
Assessment of relaxin levels in pregnant women with gestational diabetes mellitus [PDF]
Iftikhar Zaman +4 more
openalex +1 more source

